ConductScience.org, home

Paper · 42978490

The Potential Role of Gut Microbiome Dysbiosis and Functional Reprogramming in Colorectal Liver Metastasis via the Gut-Liver Axis.

Sheng Y and 4 others. Cancer Rep (Hoboken), 2026.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The Potential Role of Gut Microbiome Dysbiosis and Functional Reprogramming in Colorectal Liver Metastasis via the Gut-Liver Axis. Papers, record 42978490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42978490

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Potential Role of Gut Microbiome Dysbiosis and Functional Reprogramming in Colorectal Liver Metastasis via the Gut-Liver Axis.
Journal
Cancer Rep (Hoboken)
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-11-06

Source PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sheng YYuejin
2Dai XXiaoyu
3Lu JJiaqi
4Zhang HHao
5Cai PPinghttps://orcid.org/0000-0003-4395-2055

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Liver NeoplasmsMajor topic
Colorectal NeoplasmsMajor topic
DysbiosisMajor topic
Gastrointestinal MicrobiomeMajor topic
Humans
Male
Female
Feces
Middle Aged
Aged
Liver
Case-Control Studies
Metagenomics
Biomarkers, Tumor

Source PubMed

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2024KY1551Medical Scientific Research Foundation of Zhejiang Province, ChinaPubMed
2025KY1386Medical Scientific Research Foundation of Zhejiang Province, ChinaPubMed
2025KY1503Medical Scientific Research Foundation of Zhejiang Province, ChinaPubMed
2024Z229Science and Technology Innovation Yongjiang 2035 Key Research and Development Project of NingboPubMed
2022E50008Zhejiang Provincial Clinical Research Center for CANCERPubMed
2024ZY01056Zhejiang Provincial Clinical Research Center for CANCERPubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References74

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121,111,231Pathogen-mediated posttranslational modifications: A re-emerging field.Cell2010https://conductscience.org/library/papers/21111231PubMed
215,729,348Functional cartography of complex metabolic networks.Nature2005https://conductscience.org/library/papers/15729348PubMed
324,695,404Trimmomatic: a flexible trimmer for Illumina sequence data.Bioinformatics2014https://conductscience.org/library/papers/24695404PubMed
429,170,280Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer.Science2017https://conductscience.org/library/papers/29170280PubMed
526,684,538Bacterial ferrous iron transport: the Feo system.FEMS Microbiol Rev2016https://conductscience.org/library/papers/26684538PubMed
631,455,888Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies.Nat Rev Gastroenterol Hepatol2019https://conductscience.org/library/papers/31455888PubMed
733,277,504Deciphering functional redundancy in the human microbiome.Nat Commun2020https://conductscience.org/library/papers/33277504PubMed
836,992,683Tumor bacterial markers diagnose the initiation and four stages of colorectal cancer.Front Cell Infect Microbiol2023https://conductscience.org/library/papers/36992683PubMed
925,758,642Gut microbiome development along the colorectal adenoma-carcinoma sequence.Nat Commun2015https://conductscience.org/library/papers/25758642PubMed
1016,731,699Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences.Bioinformatics2006https://conductscience.org/library/papers/16731699PubMed

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42978490

GET https://conductscience.org/api/papers/v1/42978490/references?page=2